English
简体中文
Total: £ 56.28
Published Date: 2026-04-10 | Pages: 115 | Tables: 113 | Medical Care
The global Photodynamic Therapy Drugs (PTD) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Photodynamic therapy drugs (PTD) are photosensitizing agents used in photodynamic therapy, a non-invasive medical treatment that involves the administration of light-sensitive drugs followed by exposure to specific wavelengths of light to target and destroy abnormal cells, such as cancer cells or skin lesions.
The North American market for Photodynamic Therapy Drugs (PTD) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Photodynamic Therapy Drugs (PTD) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Photodynamic Therapy Drugs (PTD) in Pancreatic Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Photodynamic Therapy Drugs (PTD) include DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, Biofrontera, Merck, QIYUE BIOLOGY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Guangsheng Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Photodynamic Therapy Drugs (PTD) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Photodynamic Therapy Drugs (PTD). The Photodynamic Therapy Drugs (PTD) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Photodynamic Therapy Drugs (PTD) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Photodynamic Therapy Drugs (PTD) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
DUSA Pharmaceuticals
Soligenix
ORALIA
Theralase
Quest Pharmatech
Biofrontera
Merck
QIYUE BIOLOGY
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Shanghai Guangsheng Pharmaceutical
APExBIO Technology
Thermo Fisher
Segment by Type
Aminolevulinic Acid
Hemoporfin
Sinoporphyrin Sodium
Others
Segment by Application
Pancreatic Cancer
Esophageal Cancer
Skin Cancer
Lung Cancer
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Photodynamic Therapy Drugs (PTD) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Aminolevulinic Acid
1.2.3 Hemoporfin
1.2.4 Sinoporphyrin Sodium
1.2.5 Others
1.3 Market by Application
1.3.1 Global Photodynamic Therapy Drugs (PTD) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pancreatic Cancer
1.3.3 Esophageal Cancer
1.3.4 Skin Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Photodynamic Therapy Drugs (PTD) Market Perspective (2021–2032)
2.2 Global Photodynamic Therapy Drugs (PTD) Growth Trends by Region
2.2.1 Global Photodynamic Therapy Drugs (PTD) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Photodynamic Therapy Drugs (PTD) Historic Market Size by Region (2021–2026)
2.2.3 Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Region (2027–2032)
2.3 Photodynamic Therapy Drugs (PTD) Market Dynamics
2.3.1 Photodynamic Therapy Drugs (PTD) Industry Trends
2.3.2 Photodynamic Therapy Drugs (PTD) Market Drivers
2.3.3 Photodynamic Therapy Drugs (PTD) Market Challenges
2.3.4 Photodynamic Therapy Drugs (PTD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Photodynamic Therapy Drugs (PTD) Players by Revenue
3.1.1 Global Top Photodynamic Therapy Drugs (PTD) Players by Revenue (2021–2026)
3.1.2 Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Players (2021–2026)
3.2 Global Top Photodynamic Therapy Drugs (PTD) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Photodynamic Therapy Drugs (PTD) Revenue
3.4 Global Photodynamic Therapy Drugs (PTD) Market Concentration Ratio
3.4.1 Global Photodynamic Therapy Drugs (PTD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Photodynamic Therapy Drugs (PTD) Revenue in 2025
3.5 Global Key Players of Photodynamic Therapy Drugs (PTD) Head Offices and Areas Served
3.6 Global Key Players of Photodynamic Therapy Drugs (PTD), Products and Applications
3.7 Global Key Players of Photodynamic Therapy Drugs (PTD), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Photodynamic Therapy Drugs (PTD) Breakdown Data by Type
4.1 Global Photodynamic Therapy Drugs (PTD) Historic Market Size by Type (2021–2026)
4.2 Global Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Type (2027–2032)
5 Photodynamic Therapy Drugs (PTD) Breakdown Data by Application
5.1 Global Photodynamic Therapy Drugs (PTD) Historic Market Size by Application (2021–2026)
5.2 Global Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Photodynamic Therapy Drugs (PTD) Market Size (2021–2032)
6.2 North America Photodynamic Therapy Drugs (PTD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Photodynamic Therapy Drugs (PTD) Market Size by Country (2021–2026)
6.4 North America Photodynamic Therapy Drugs (PTD) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Photodynamic Therapy Drugs (PTD) Market Size (2021–2032)
7.2 Europe Photodynamic Therapy Drugs (PTD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Photodynamic Therapy Drugs (PTD) Market Size by Country (2021–2026)
7.4 Europe Photodynamic Therapy Drugs (PTD) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size (2021–2032)
8.2 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region (2021–2026)
8.4 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Photodynamic Therapy Drugs (PTD) Market Size (2021–2032)
9.2 Latin America Photodynamic Therapy Drugs (PTD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Photodynamic Therapy Drugs (PTD) Market Size by Country (2021–2026)
9.4 Latin America Photodynamic Therapy Drugs (PTD) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size (2021–2032)
10.2 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country (2021–2026)
10.4 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DUSA Pharmaceuticals
11.1.1 DUSA Pharmaceuticals Company Details
11.1.2 DUSA Pharmaceuticals Business Overview
11.1.3 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Introduction
11.1.4 DUSA Pharmaceuticals Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.1.5 DUSA Pharmaceuticals Recent Development
11.2 Soligenix
11.2.1 Soligenix Company Details
11.2.2 Soligenix Business Overview
11.2.3 Soligenix Photodynamic Therapy Drugs (PTD) Introduction
11.2.4 Soligenix Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.2.5 Soligenix Recent Development
11.3 ORALIA
11.3.1 ORALIA Company Details
11.3.2 ORALIA Business Overview
11.3.3 ORALIA Photodynamic Therapy Drugs (PTD) Introduction
11.3.4 ORALIA Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.3.5 ORALIA Recent Development
11.4 Theralase
11.4.1 Theralase Company Details
11.4.2 Theralase Business Overview
11.4.3 Theralase Photodynamic Therapy Drugs (PTD) Introduction
11.4.4 Theralase Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.4.5 Theralase Recent Development
11.5 Quest Pharmatech
11.5.1 Quest Pharmatech Company Details
11.5.2 Quest Pharmatech Business Overview
11.5.3 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Introduction
11.5.4 Quest Pharmatech Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.5.5 Quest Pharmatech Recent Development
11.6 Biofrontera
11.6.1 Biofrontera Company Details
11.6.2 Biofrontera Business Overview
11.6.3 Biofrontera Photodynamic Therapy Drugs (PTD) Introduction
11.6.4 Biofrontera Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.6.5 Biofrontera Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Photodynamic Therapy Drugs (PTD) Introduction
11.7.4 Merck Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.7.5 Merck Recent Development
11.8 QIYUE BIOLOGY
11.8.1 QIYUE BIOLOGY Company Details
11.8.2 QIYUE BIOLOGY Business Overview
11.8.3 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Introduction
11.8.4 QIYUE BIOLOGY Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.8.5 QIYUE BIOLOGY Recent Development
11.9 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
11.9.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Details
11.9.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Business Overview
11.9.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Introduction
11.9.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.9.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Development
11.10 Shanghai Guangsheng Pharmaceutical
11.10.1 Shanghai Guangsheng Pharmaceutical Company Details
11.10.2 Shanghai Guangsheng Pharmaceutical Business Overview
11.10.3 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Introduction
11.10.4 Shanghai Guangsheng Pharmaceutical Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.10.5 Shanghai Guangsheng Pharmaceutical Recent Development
11.11 APExBIO Technology
11.11.1 APExBIO Technology Company Details
11.11.2 APExBIO Technology Business Overview
11.11.3 APExBIO Technology Photodynamic Therapy Drugs (PTD) Introduction
11.11.4 APExBIO Technology Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.11.5 APExBIO Technology Recent Development
11.12 Thermo Fisher
11.12.1 Thermo Fisher Company Details
11.12.2 Thermo Fisher Business Overview
11.12.3 Thermo Fisher Photodynamic Therapy Drugs (PTD) Introduction
11.12.4 Thermo Fisher Revenue in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
11.12.5 Thermo Fisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Aminolevulinic Acid
Table 3. Key Players of Hemoporfin
Table 4. Key Players of Sinoporphyrin Sodium
Table 5. Key Players of Others
Table 6. Global Photodynamic Therapy Drugs (PTD) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Photodynamic Therapy Drugs (PTD) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Photodynamic Therapy Drugs (PTD) Market Size by Region (US$ Million), 2021–2026
Table 9. Global Photodynamic Therapy Drugs (PTD) Market Share by Region (2021–2026)
Table 10. Global Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Photodynamic Therapy Drugs (PTD) Market Share by Region (2027–2032)
Table 12. Photodynamic Therapy Drugs (PTD) Market Trends
Table 13. Photodynamic Therapy Drugs (PTD) Market Drivers
Table 14. Photodynamic Therapy Drugs (PTD) Market Challenges
Table 15. Photodynamic Therapy Drugs (PTD) Market Restraints
Table 16. Global Photodynamic Therapy Drugs (PTD) Revenue by Players (US$ Million), 2021–2026
Table 17. Global Photodynamic Therapy Drugs (PTD) Market Share by Players (2021–2026)
Table 18. Global Top Photodynamic Therapy Drugs (PTD) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Photodynamic Therapy Drugs (PTD) Revenue, 2025
Table 19. Ranking of Global Top Photodynamic Therapy Drugs (PTD) Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Photodynamic Therapy Drugs (PTD) Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Photodynamic Therapy Drugs (PTD), Headquarters and Area Served
Table 22. Global Key Players of Photodynamic Therapy Drugs (PTD), Products and Applications
Table 23. Global Key Players of Photodynamic Therapy Drugs (PTD), Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Photodynamic Therapy Drugs (PTD) Market Size by Type (US$ Million), 2021–2026
Table 26. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Type (2021–2026)
Table 27. Global Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Type (2027–2032)
Table 29. Global Photodynamic Therapy Drugs (PTD) Market Size by Application (US$ Million), 2021–2026
Table 30. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Application (2021–2026)
Table 31. Global Photodynamic Therapy Drugs (PTD) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Photodynamic Therapy Drugs (PTD) Revenue Market Share by Application (2027–2032)
Table 33. North America Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2021–2026
Table 35. North America Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country (US$ Million), 2027–2032
Table 48. DUSA Pharmaceuticals Company Details
Table 49. DUSA Pharmaceuticals Business Overview
Table 50. DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Product
Table 51. DUSA Pharmaceuticals Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 52. DUSA Pharmaceuticals Recent Development
Table 53. Soligenix Company Details
Table 54. Soligenix Business Overview
Table 55. Soligenix Photodynamic Therapy Drugs (PTD) Product
Table 56. Soligenix Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 57. Soligenix Recent Development
Table 58. ORALIA Company Details
Table 59. ORALIA Business Overview
Table 60. ORALIA Photodynamic Therapy Drugs (PTD) Product
Table 61. ORALIA Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 62. ORALIA Recent Development
Table 63. Theralase Company Details
Table 64. Theralase Business Overview
Table 65. Theralase Photodynamic Therapy Drugs (PTD) Product
Table 66. Theralase Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 67. Theralase Recent Development
Table 68. Quest Pharmatech Company Details
Table 69. Quest Pharmatech Business Overview
Table 70. Quest Pharmatech Photodynamic Therapy Drugs (PTD) Product
Table 71. Quest Pharmatech Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 72. Quest Pharmatech Recent Development
Table 73. Biofrontera Company Details
Table 74. Biofrontera Business Overview
Table 75. Biofrontera Photodynamic Therapy Drugs (PTD) Product
Table 76. Biofrontera Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 77. Biofrontera Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Photodynamic Therapy Drugs (PTD) Product
Table 81. Merck Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 82. Merck Recent Development
Table 83. QIYUE BIOLOGY Company Details
Table 84. QIYUE BIOLOGY Business Overview
Table 85. QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Product
Table 86. QIYUE BIOLOGY Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 87. QIYUE BIOLOGY Recent Development
Table 88. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Details
Table 89. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Business Overview
Table 90. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Product
Table 91. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 92. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Development
Table 93. Shanghai Guangsheng Pharmaceutical Company Details
Table 94. Shanghai Guangsheng Pharmaceutical Business Overview
Table 95. Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Product
Table 96. Shanghai Guangsheng Pharmaceutical Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 97. Shanghai Guangsheng Pharmaceutical Recent Development
Table 98. APExBIO Technology Company Details
Table 99. APExBIO Technology Business Overview
Table 100. APExBIO Technology Photodynamic Therapy Drugs (PTD) Product
Table 101. APExBIO Technology Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 102. APExBIO Technology Recent Development
Table 103. Thermo Fisher Company Details
Table 104. Thermo Fisher Business Overview
Table 105. Thermo Fisher Photodynamic Therapy Drugs (PTD) Product
Table 106. Thermo Fisher Revenue in Photodynamic Therapy Drugs (PTD) Business (US$ Million), 2021–2026
Table 107. Thermo Fisher Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Photodynamic Therapy Drugs (PTD) Picture
Figure 2. Global Photodynamic Therapy Drugs (PTD) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Photodynamic Therapy Drugs (PTD) Market Share by Type: 2025 vs 2032
Figure 4. Aminolevulinic Acid Features
Figure 5. Hemoporfin Features
Figure 6. Sinoporphyrin Sodium Features
Figure 7. Others Features
Figure 8. Global Photodynamic Therapy Drugs (PTD) Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Photodynamic Therapy Drugs (PTD) Market Share by Application: 2025 vs 2032
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Esophageal Cancer Case Studies
Figure 12. Skin Cancer Case Studies
Figure 13. Lung Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Photodynamic Therapy Drugs (PTD) Report Years Considered
Figure 16. Global Photodynamic Therapy Drugs (PTD) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 17. Global Photodynamic Therapy Drugs (PTD) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Photodynamic Therapy Drugs (PTD) Market Share by Region: 2025 vs 2032
Figure 19. Global Photodynamic Therapy Drugs (PTD) Market Share by Players in 2025
Figure 20. Global Photodynamic Therapy Drugs (PTD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Photodynamic Therapy Drugs (PTD) Revenue in 2025
Figure 22. North America Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. North America Photodynamic Therapy Drugs (PTD) Market Share by Country (2021–2032)
Figure 24. United States Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Canada Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Photodynamic Therapy Drugs (PTD) Market Share by Country (2021–2032)
Figure 28. Germany Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. France Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. U.K. Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Italy Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Russia Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Ireland Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Share by Region (2021–2032)
Figure 36. China Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Japan Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. South Korea Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Southeast Asia Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. India Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Australia & New Zealand Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Photodynamic Therapy Drugs (PTD) Market Share by Country (2021–2032)
Figure 44. Mexico Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Brazil Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Share by Country (2021–2032)
Figure 48. Israel Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Saudi Arabia Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. UAE Photodynamic Therapy Drugs (PTD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. DUSA Pharmaceuticals Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 52. Soligenix Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 53. ORALIA Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 54. Theralase Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 55. Quest Pharmatech Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 56. Biofrontera Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 57. Merck Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 58. QIYUE BIOLOGY Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 59. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 60. Shanghai Guangsheng Pharmaceutical Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 61. APExBIO Technology Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 62. Thermo Fisher Revenue Growth Rate in Photodynamic Therapy Drugs (PTD) Business (2021–2026)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
